Sangamo Therapeutics, Inc 8-K, filed Oct 16, 2026

About this 8-K

Items reported

Sangamo Therapeutics, Inc (SGMOQ)

8-K 2026-10-16 For: 2026-10-14

Added on October 17, 2026

Sangamo Therapeutics, Inc filed this 8-K on October 16, 2026, reporting on events of October 14, 2026.

Sangamo Therapeutics filed its monthly operating report for August 2026 in its Chapter 11 case. It reported a net loss of -14,449,029 (cumulative -29,369,386), cash receipts of 10,145,433, disbursements of 3,826,691, and an ending cash balance of 23,225,696. AI summary

SANGAMO THERAPEUTICS, INC.

Date: October 15, 2026

/s/ SCOTT B. WILLOUGHBY

Scott B. Willoughby

Chief Legal Officer and Corporate Secretary

Item 7.01: Regulation FD disclosure
Item 9.01: Financial statements and exhibits

Search and read filings like this one from Claude or ChatGPT with the SEC filings MCP server →


Exhibit Number		Description of Document

99.1		Sangamo Therapeutics, Inc. Monthly Operating Report for the period ended August 31, 2026.

104		Cover Page Interactive Data File (embedded within the Inline XBRL document).


In Re. SANGAMO THERAPEUTICS, INC.	§	Case No. 26-10989
	§
	§
Debtor(s)	§
		☐ Jointly Administered


Monthly Operating Report			Chapter 11

Reporting Period Ended: 08/31/2026		Petition Date: 06/23/2026

Months Pending: 2		Industry Classification:

Reporting Method:	Accrual Basis	Cash Basis

Debtor’s Full-Time Employees (current):		73

Debtor’s Full-Time Employees (as of date of order for relief):		74


/s/ Nikunj Jain				Nikunj Jain
Signature of Responsible Party				Printed Name of Responsible Party

10/14/2026
Date

				501 Canal Blvd., Suite A100 Richmond, CA 94804
				Address


Part 1: Cash Receipts and Disbursements		Current Month		Cumulative
a.	Cash balance beginning of month	$	16,906,954

b.	Total receipts (net of transfers between accounts)	$	10,145,433	$	38,707,494

c.	Total disbursements (net of transfers between accounts)	$	3,826,691	$	20,338,902

d.	Cash balance end of month (a+b-c)	$	23,225,696

e.	Disbursements made by third party for the benefit of the estate	$	0	$	0

f.	Total disbursements for quarterly fee calculation (c+e)	$	3,826,691	$	20,338,902


Part 2: Asset and Liability Status (Not generally applicable to Individual Debtors. See Instructions.)		Current Month
a.	Accounts receivable (total net of allowance)	$	90,355

b.	Accounts receivable over 90 days outstanding (net of allowance)	$	90,355

c.	Inventory (Book Market Other (attach explanation))	$	0

d	Total current assets	$	25,398,606

e.	Total assets	$	147,881,705

f.	Postpetition payables (excluding taxes)	$	28,270,062

g.	Postpetition payables past due (excluding taxes)	$	768,173

h.	Postpetition taxes payable	$	308,160

i.	Postpetition taxes past due	$	0

j.	Total postpetition debt (f+h)	$	28,578,222

k.	Prepetition secured debt	$	0

l.	Prepetition priority debt	$	32,543

m.	Prepetition unsecured debt	$	78,651,484

n.	Total liabilities (debt) (j+k+l+m)	$	107,262,249

o.	Ending equity/net worth (e-n)	$	40,619,456


Part 3: Assets Sold or Transferred		Current Month		Cumulative
a.	Total cash sales price for assets sold/transferred outside the ordinary course of business	$	2,300,000	$	2,300,000

b.	Total payments to third parties incident to assets being sold/transferred outside the ordinary course of business	$	0	$	0

c.	Net cash proceeds from assets sold/transferred outside the ordinary course of business (a-b)	$	2,300,000	$	2,300,000


Part 4: Income Statement (Statement of Operations) (Not generally applicable to Individual Debtors. See Instructions.)		Current Month		Cumulative
a.	Gross income/sales (net of returns and allowances)	$	430,190

b.	Cost of goods sold (inclusive of depreciation, if applicable)	$	0

c.	Gross profit (a-b)	$	430,190

d.	Selling expenses	$	0

e.	General and administrative expenses	$	3,679,482

f.	Other expenses	$	602,848

g.	Depreciation and/or amortization (not included in 4b)	$	137,645

h.	Interest	$	192,082

i.	Taxes (local, state, and federal)	$	0

j.	Reorganization items	$	9,979,799

k.	Profit (loss)	$	-14,449,029	$	-29,369,386


Part 6: Postpetition Taxes	Current Month		Cumulative
a. Postpetition income taxes accrued (local, state, and federal)	$	0	$	0

b. Postpetition income taxes paid (local, state, and federal)	$	0	$	0

c. Postpetition employer payroll taxes accrued	$	211,413	$	493,588

d. Postpetition employer payroll taxes paid	$	455,499	$	877,333

e. Postpetition property taxes paid	$	361,948	$	361,948

f. Postpetition other taxes accrued (local, state, and federal)	$	96,747	$	154,151

g. Postpetition other taxes paid (local, state, and federal)	$	0	$	0


Part 7: Questionnaire - During this reporting period:

a. Were any payments made on prepetition debt? (if yes, see Instructions)	Yes	No

b. Were any payments made outside the ordinary course of business without court approval? (if yes, see Instructions)	Yes	No

c. Were any payments made to or on behalf of insiders?	Yes	No

d. Are you current on postpetition tax return filings?	Yes	No

e. Are you current on postpetition estimated tax payments?	Yes	No

f. Were all trust fund taxes remitted on a current basis?	Yes	No

g. Was there any postpetition borrowing, other than trade credit? (if yes, see Instructions)	Yes	No

h. Were all payments made to or on behalf of professionals approved by the court?	Yes	No	N/A

i. Do you have: Worker’s compensation insurance?	Yes	No

If yes, are your premiums current?	Yes	No	N/A (if no, see Instructions)

Casualty/property insurance?	Yes	No

If yes, are your premiums current?	Yes	No	N/A (if no, see Instructions)

General liability insurance?	Yes	No

If yes, are your premiums current?	Yes	No	N/A (if no, see Instructions)

j. Has a plan of reorganization been filed with the court?	Yes	No

k. Has a disclosure statement been filed with the court?	Yes	No

l. Are you current with quarterly U.S. Trustee fees as set forth under 28 U.S.C. § 1930?	Yes	No


Part 8: Individual Chapter 11 Debtors (Only)
a. Gross income (receipts) from salary and wages				$ 0

b. Gross income (receipts) from self-employment				$ 0

c. Gross income from all other sources				$ 0

d. Total income in the reporting period (a+b+c)				$ 0

e. Payroll deductions				$ 0

f. Self-employment related expenses				$ 0

g. Living expenses				$ 0

h. All other expenses				$ 0

i. Total expenses in the reporting period (e+f+g+h)				$ 0

j. Difference between total income and total expenses (d-i)				$ 0

k. List the total amount of all postpetition debts that are past due				$ 0

l. Are you required to pay any Domestic Support Obligations as defined by 11 U.S.C § 101(14A)?	Yes	No
m. If yes, have you made all Domestic Support Obligation payments?	Yes	No	N/A


	)
In re:	)	Chapter 11
	)
SANGAMO THERAPEUTICS, INC.	)	Case No. 26-10989 (CTG)
	)
Debtor.¹	)
	)


/s/ Nikunj Jain				October 14, 2026
Signature of Authorized Individual				Date

Nikunj Jain				Interim Chief Financial Officer
Printed Name of Authorized Individual				Title of Authorized Individual


	07/01/2026 - 07/31/2026		08/01/2026 - 08/31/2026
Receipts
Receipts	$	59	$	3,145
DIP Draw	$	18,000	$	7,000

Total Receipts	$	18,059	$	10,145
Operational Disbursements
Payroll & Benefits	$	1,747	$	1,693
Rent & Facilities		1,348		319
Program Costs		319		226
International Operations		416		240
Other Operating Disbursements		271		579

Total Operational Disbursements	$	4,101	$	3,057
Restructuring Disbursements
Professional Fees		—	$	515
US Trustee Fees		—		4
DIP Interest & Fees		933		250
DIP Repayments		10,500		—

Total Restructuring Disbursements	$	11,433	$	769
Net Cash Flow	$	2,525	$	6,319
Cash, cash equivalents, and restricted cash, beginning of period	$	14,382	$	16,907

Cash, cash equivalents, and restricted cash, end of period	$	16,907	$	23,226


	As of
	07/31/2026			08/31/2026
Assets
Cash, Cash Equivalents and Restricted Cash		$ 16,910			$ 23,197
Accounts Receivables		500			90
Other Current Assets		2,977			2,111

Total Current Assets		$ 20,387			$ 25,399
Property, Plant & Equipment (Net)		$ 9,430			$2
Right of Use Assets³		2,694			—
Other Non-Current Assets		779			613
Investments in Subsidiaries		115,762			115,762
I/C Receivables - Non-Current		6,067			6,106

Total Non-Current Assets		$ 134,731			$ 122,483

Total Assets		$ 155,118			$ 147,882

Liabilities and Stockholders’ Equity
A/P and Accrued Liabilities		$ 36,735			$ 44,182
Compensation and Benefits Liabilities		17,304			17,397
DIP Loan Payables²		18,000			24,942
Other Current Liabilities¹		8,713			9,723
I/C Payables - Current		42,687			42,903
Other Non-Current Liabilities¹		23,240			14,754
I/C Payables - Non-Current		703			708

Total Liabilities		$ 147,383			$ 154,609
Stock		$ 1,643,342			$ 1,643,328
Retained Earnings		(1,564,836	)		(1,564,836	)
Other Equity		(30	)		(30	)
Net Income		(70,741	)		(85,190	)
Total Stockholders’ Equity		$ 7,735			($ 6,727	)

Total Liabilities and Stockholders’ Equity		$ 155,118			$ 147,882


	07/01/2026 - 07/31/2026			08/01/2026 - 08/31/2026
Total Revenue		$ 720			$ 430
COGS		—			—

Gross Profit		$ 720			$ 430
Personnel & Staffing Costs¹		$ 1,931			$ 1,693
R&D Expenses²		3,184			473
Selling Expenses		—			—
General and Administrative Expenses⁴		863			1,037
Facilities & OH Expenses¹		972			950
I/C Expenses²		28			127
Other Expenses²		19			3
Interest Expense		105			192
Restructuring Expenses³		4,244			9,980
Depreciation and/or amortization		216			138

Total Operating Expenses		$ 11,562			$ 14,592
Unrealized FX (Gain)/Loss		$ 336			$ 292
Non-Operating (Income)/Expense		(12	)		(5	)

Total Non-Operating (Income)/Expense		$ 323			$ 287

Net Profit/(Loss) for the Period		($ 11,165	)		($ 14,449	)


Detail	Date	Payee/Lender Name	Amount
DIP draw	8/21/2026	Future Solution Investments LLC	$	7,000,000


UST Form 11-MOR (12/01/2021)		1


UST Form 11-MOR (12/01/2021)		2


UST Form 11-MOR (12/01/2021)		3


UST Form 11-MOR (12/01/2021)		4